Dianthus Therapeutics (Dianthus Therapeutics) Ending Cash Position : $329.79 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Dianthus Therapeutics Ending Cash Position?

Dianthus Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 was $329.79 Mil.

Dianthus Therapeutics's quarterly Ending Cash Position increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($132.39 Mil) and increased from Dec. 2023 ($132.39 Mil) to Mar. 2024 ($329.79 Mil).

Dianthus Therapeutics's annual Ending Cash Position increased from Dec. 2021 ($7.64 Mil) to Dec. 2022 ($15.43 Mil) and increased from Dec. 2022 ($15.43 Mil) to Dec. 2023 ($132.39 Mil).

Dianthus Therapeutics Ending Cash Position Historical Data

The historical data trend for Dianthus Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dianthus Therapeutics Ending Cash Position Chart

Dianthus Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Ending Cash Position

7.64

15.43

132.39

Dianthus Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial			15.43	23.27	-	132.39	329.79

Dianthus Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Dianthus Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	15.425	+	116.966
	=	132.39

Dianthus Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	132.391	+	197.399
	=	329.79

Dianthus Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Dianthus Therapeutics (Dianthus Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dianthus Therapeutics Inc (NAS:DNTH) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

87E:Germany

Address

7 Times Square, 43rd Floor, New York, NY, USA, 10036

Website

https://www.dianthustx.com

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is comprised of an experienced team of biotech and pharma executives who are leading the next generation of antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune diseases.

Dianthus Therapeutics (Dianthus Therapeutics) Headlines

From GuruFocus

Insider Buying: Fairmount Funds Management LLC Acquires 24,254 Shares of Dianthus Therapeutics Inc

By GuruFocus Research • 09-14-2023

Fairmount Funds Management LLC Acquires New Stake in Dianthus Therapeutics Inc

By GuruFocus Research • 09-29-2023